Brain leptomeningeal enhancement and cranial nerve enhancement in a pediatric-onset multiple sclerosis patient during fingolimod rebound: A case report

Autor: Karazanashvili, Nikoloz, Diaz, Monica M., Almodovar, Jorge L., Javed, Bushra, Iyer, Stephanie, Dujmovic Basuroski, Irena

Publikováno v: In Neuroimmunology Reports December 2024 6

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Impact of discontinuing disease-modifying therapies on health care utilization among midlife patients with multiple sclerosis in the United States.

Autor: Qian Y; Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill., Thorpe CT; Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill.; Center for Health Equity Research and Promotion, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, PA., Tak C; Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City., Iyer S; Department of Pharmacy, University of North Carolina Health, Chapel Hill., Seyerle A; Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill., Thorpe JM; Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill.; Center for Health Equity Research and Promotion, Veterans Affairs Pittsburgh Healthcare System, Pittsburgh, PA.

Publikováno v: Journal of managed care & specialty pharmacy [J Manag Care Spec Pharm] 2024 Nov; Vol. 30 (11), pp. 1248-1260.